|
TOP STORY |
Vascularized and Functional Human Liver from an iPSC-Derived Organ Bud Transplant Researchers showed the generation of vascularized and functional human liver from human induced pluripotent stem cells (hiPSCs) by transplantation of in vitro grown liver buds (rudimentary liver). This study demonstrates a proof-of-concept that organ bud transplantation offers an alternative approach for treating organ failure by generating a 3D and vascularized organ. [Press release from Yokohama City University discussing online prepublication in Nature] Press Release | Abstract |
PUBLICATIONS (Ranked by impact factor of the journal) |
Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients with De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis Researchers evaluated reduced-intensity conditioning transplantation versus nontransplantation therapies in older patients with myelodysplastic syndromes stratified by International Prognostic Scoring System risk. [J Clin Oncol] Abstract | Press Release Whole Body Correction of Mucopolysaccharidosis IIIA by Intracerebrospinal Fluid Gene Therapy The Transfer of Host MHC Class I Protein Protects Donor Cells from NK Cell and Macrophage Mediated Rejection during Hematopoietic Stem Cell Transplantation and Engraftment in Mice Reversing Bone Loss by Directing Mesenchymal Stem Cells to the Bone Engineered Neural Tissue for Peripheral Nerve Repair Autologous Myoblast Transplantation for Oculopharyngeal Muscular Dystrophy: A Phase I/IIa Clinical Study Persistence and Efficacy of Second Generation CAR-T Cell against the LeY Antigen in Acute Myeloid Leukemia Lentivirus-Mediated CD/TK Fusion Gene Transfection Neural Stem Cell Therapy for C6 Glioblastoma |
REVIEWS |
Induced Regeneration – The Progress and Promise of Direct Reprogramming for Heart Repair In this review the authors examine key developments in the generation of new cardiomyocytes in vitro as well as the exciting progress that has been made toward in vivo reprogramming of cardiac tissue. [Nat Med] Abstract Immunotherapy with Gene-Modified T Cells: Limiting Side Effects Provides New Challenges Visit our reviews page to see a complete list of reviews in the cell, gene and immunotherapy research field. |
SCIENCE NEWS |
Stem-Cell Transplants May Purge HIV Two men with HIV may have been cured after they received stem-cell transplants to treat the blood cancer lymphoma, their doctors announced. Last July, doctors announced that the two men – the ‘Boston patients’ – appeared to be living without detectable levels of HIV in their blood, but they were still taking antiretroviral medications at that time. Timothy Henrich, an HIV specialist at Brigham and Women’s Hospital in Boston, Massachusetts, who helped to treat the men, says that they have now stopped their antiretroviral treatments with no ill effects. [Press release from Nature News discussing research presented at the International AIDS Society Conference, Kuala Lumpur] Press Release Alnylam Presents New Pre-Clinical Data on ALN-AT3, an RNAi Therapeutic Targeting Antithrombin (AT) for the Treatment of Hemophilia and Rare Bleeding Disorders |
POLICY |
European Deal Cuts Red Tape A deal struck during negotiations on the research program for the next seven years in the European Union promises a significant change to the way in which institutions are reimbursed for the overhead costs of their research. The agreement for Horizon 2020 sweeps away the onerous red tape involved in the present diverse arrangements and replaces it with an across-the-board 25% reimbursement rate for all. [European Commission, European Union] Press Release Anger as Spanish Funder Claws Back Science Money Japan’s Science Policy Council Expands Role |
BUSINESS |
LLS and Johns Hopkins Collaborate on a Phase II Clinical Trial to Advance Innovative Immunotherapy for Multiple Myeloma Patients The Leukemia & Lymphoma Society (LLS) announced a collaboration with Johns Hopkins University School of Medicine to advance a novel adoptive immunotherapy for patients with poor prognosis myeloma, a blood cancer. The approach shows promise for patients with other blood cancers as well. [The Leukemia & Lymphoma Society] Press Release Fondation Leducq Awards $6 Million Grant for Global Research Network for Cardiac Regeneration Nanofiber Solutions Receives Award from Ohio Third Frontier to Further Develop Tissue Engineered Intestine Technology Cellectis Group Announces Groundbreaking In Vivo Proof of Concept Testing of Their Flagship UCART19 Product for Curative Therapy of Leukemia Gamida Cell Reports FDA Recommending Further Study of StemEx® Activartis’ Cancer Immunotherapy Receives Orphan Drug Designation from FDA Transgene Grants Ascend Biopharmaceuticals a License to TG1042, an Immunotherapy to Treat Basal Cell Carcinoma, a Common Type of Skin Cancer Dicerna Announces Additional Patent Claims Allowed, Broadening Coverage of Extended Dicer Substrate Therapeutic Structures |
NIH |
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24) (PAR-13-252) Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2013-16081) |
CBER |
Draft Guidance for Industry: Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products |
EVENTS |
NEW The Jackson Laboratory: Modeling Human Disease with Diet-Induced Obesity Models and Resources July 11, 1:00PM (ET in US) Webinar NEW The European Cancer Congress 2013 Visit our events page to see a complete list of events in the cell, gene and immunotherapy community. |
SUBSCRIBER TOOLS: | |||
Profile Center | Connexon Publications | Article Submission | Contact Us |